Overcoming challenges of host cell DNA removal in vaccine manufacturing
Development of Production and Purification Platformform for Influenza Vaccine
Viral-vectored vaccines: a new approach in the vaccine manufacturing process
Best Practices in Nucleic Acid Removal from Vaccine Processes
Strategic Considerations for Implementing Single-Use Technologies in Vaccine Process
Process development considerations for quality and safety of vaccines
Development of a production and purification platform for VLP vaccine candidates
Pandemic Vaccine Supply - Challenges & Opportunities: A Raw Materials Perspective
Merck Millipore holds vaccine technology seminar in South Korea
Use of single-use technology in Aseptic processing of vaccines: Application strategy and validation considerations
Production and purification of Viral vectors for gene and cell therapy applications
Accelerating vaccine development and manufacturing
Production and Purification of Virus Like Particle (VLP) based Vaccine
Pragmatic implementation of single use technologies to deliver clinical supply